Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T2Resistance 510(k) Study Protocol - Detection and Identification of Several Classes of Resistance Genes in Both Gram-positive and Gram-negative Pathogens

NCT05231187 is registered in ClinicalTrials.gov with T2 Biosystems as lead sponsor.

NCT NCT05231187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05231187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T2Resistance 510(k) Study Protocol - Detection and Identification of Several Classes of Resistance Genes in Both Gram-positive and Gram-negative Pathogens
Lead sponsor
T2 Biosystems
Phase
Observational
Overall status
Completed
Start date
January 21, 2022
Completion date
April 24, 2024
Enrollment
1,566 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

resistance bacterial